Sovilnesib 是一种有效Kinesin-like protein KIF18A抑制剂，来自专利WO2020132648。它可用于癌症的研究。

Sovilnesib is a kinesin-like protein KIF18A inhibitor (WO2020132648). Sovilnesib can be used for the cancer research.

Sovilnesib is an inhibitor of the kinesin-like protein KIF18A[1].

2410796-79-9

C26H34F2N6O4S

564.65

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years